214 related articles for article (PubMed ID: 22484291)
1. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
4. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
Kolaitis NA; Duffy E; Zhang A; Lo M; Barba DT; Chen M; Soriano T; Hu J; Nabili V; Saggar R; Sayah DM; DerHovanessian A; Shino MY; Lynch JP; Kubak BM; Ardehali A; Ross DJ; Belperio JA; Elashoff D; Saggar R; Weigt SS
Transpl Int; 2017 Jan; 30(1):41-48. PubMed ID: 27678492
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
8. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC
Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
Tang H; Shi W; Song Y; Han J
J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
[TBL] [Abstract][Full Text] [Related]
11. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
12. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
Epaulard O; Saint-Raymond C; Villier C; Charles J; Roch N; Beani JC; Leccia MT
Clin Microbiol Infect; 2010 Sep; 16(9):1362-4. PubMed ID: 19930272
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
14. A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study.
Epaulard O; Villier C; Ravaud P; Chosidow O; Blanche S; Mamzer-Bruneel MF; Thiébaut A; Leccia MT; Lortholary O
Clin Infect Dis; 2013 Dec; 57(12):e182-8. PubMed ID: 24046296
[TBL] [Abstract][Full Text] [Related]
15. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
16. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Vanacker A; Fabré G; Van Dorpe J; Peetermans WE; Maes B
Am J Transplant; 2008 Apr; 8(4):877-80. PubMed ID: 18261173
[TBL] [Abstract][Full Text] [Related]
17. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Ibrahim SF; Singer JP; Arron ST
Dermatol Surg; 2010 Nov; 36(11):1752-5. PubMed ID: 20533939
[No Abstract] [Full Text] [Related]
18. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Younus M; Mo J; Yan J; Ussetti P; Chin-Hong PV; Solé A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Aram J; Singer LG; Husain S
Am J Transplant; 2018 Jan; 18(1):113-124. PubMed ID: 28898527
[TBL] [Abstract][Full Text] [Related]
19. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
20. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
